Chandler Capital

Chandler Capital

Expertise: Technology, Pharmaceutical, Energy, GARP

Chandler Capital is the work of Ian Hartana and Vayun Chugh.

Ian Hartana is a self-taught investor whose work has been featured on Seeking Alpha under the organization AlmaStreet Capital. Being on the student advisory board of the Young Investors Society, he is a long-time advocate for the advancement of financial literacy and has competed on the international level in multiple competitions. In his free time, he enjoys exploring the intersection between behavioral science and economics through writing on the platform Medium and is currently working as an intern at a small venture capital firm.

Vayun Chugh is also a self-taught investor and is both an editor and writer for AlmaStreet Capital. He is the president of his school’s finance club alongside Ian Hartana, and has also competed in multiple international competitions. Through his ongoing research in the medical field, Vayun has developed a deep understanding of the pharmaceutical industry and knows the characteristics of an undervalued company.

Ian and Vayun’s expertise lies in finding value in undervalued companies in the tech, pharmaceutical, and energy sectors which have the potential for growth at a reasonable price. They have a long-term investment horizon and consider ESG as an increasingly important factor in their research process.

Recent Articles

3 Non-Tech Stocks With Significant Momentum Potential

Undervalued stocks are flying under the radar of investors. As such, we will highlight non-tech stocks with tremendous potential.

The 3 Most Undervalued Tech Stocks to Buy in February 2024

These undervalued tech stocks won't stay cheap for long. Here are the best companies that investors should consider.

3 Sleeper Stocks With Serious Potential to Make You a Millionaire

Investors might miss these under-the-radar stocks and miss out on gains. Here are three sleeper companies with millionaire potential.

Buy Alert: 3 Stocks Sitting in the Sweet Spot

They say timing is everything, so investors will want to take advantage of buying these stocks now instead of waiting.

Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot

Healthcare stocks to buy are not talked about as much right now, but are great stocks investors should consider adding.